当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 资产负债表

华兰生物

(002007)

  

流通市值:299.45亿  总市值:348.02亿
流通股本:15.74亿   总股本:18.29亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金993,767,308.91644,205,979.321,065,021,315.15726,146,223.63
应收票据及应收账款2,295,645,462.972,623,171,551.261,486,792,659.352,073,453,525.64
应收账款2,295,645,462.972,623,171,551.261,486,792,659.352,073,453,525.64
应收款项融资293,909,521.8132,858,614.5356,303,888.7768,127,771.32
预付款项33,532,487.6341,567,110.5933,353,272.1435,097,040.94
其他应收款合计6,603,222.237,326,316.59,085,739.598,447,789.31
存货1,673,627,088.651,704,438,784.861,798,407,403.691,639,580,655.36
一年内到期的非流动资产1,213,457,527.79888,976,319.29882,853,999.85410,000,000
其他流动资产701,173,440.021,168,694.4717,784,457.14265,985.27
流动资产平衡项目0000
流动资产合计9,326,541,857.428,603,689,842.637,716,666,447.387,788,606,531.76
非流动资产:
长期股权投资26,440,405.1632,115,225.5736,086,858.5444,635,582.07
固定资产2,055,070,356.282,063,040,869.892,066,147,748.742,037,934,280.26
在建工程661,513,007.72416,803,753.44242,975,361.26243,567,487.52
生产性生物资产965,100.051,569,901.71349,001.83236,944.89
使用权资产9,516,048.059,644,643.319,773,238.559,911,833.79
无形资产319,715,855.87317,228,840.04322,011,955.2308,352,263.97
开发支出26,269,230.6425,772,432.1725,021,768.8924,276,738.96
商誉1,098,329.81,098,329.81,098,329.81,098,329.8
长期待摊费用33,331,687.5524,395,368.8926,018,509.2115,669,964.49
递延所得税资产241,724,551.62234,889,527.8227,155,705.72226,311,180.18
其他非流动资产3,403,596,865.033,801,230,457.433,819,501,815.554,380,728,007.85
非流动资产平衡项目0000
非流动资产合计6,779,241,437.776,927,789,350.056,776,140,293.297,292,722,613.78
资产平衡项目0000
资产总计16,105,783,295.1915,531,479,192.6814,492,806,740.6715,081,329,145.54
流动负债:
短期借款700,350,000600,000,000800,000,000800,000,000
应付票据及应付账款197,262,756.35205,766,704.85209,346,463.7212,683,481.45
其中:应付票据-3,130,00018,512,44010,072,110
应付账款197,262,756.35202,636,704.85190,834,023.7202,611,371.45
合同负债8,573,054.111,106,766.999,506,887.511,309,128.12
应付职工薪酬27,887.191,210,551.88479,223.68409,253.99
应交税费87,748,157.27145,465,223.9740,524,531.5848,383,562.65
其他应付款合计1,286,876,534.11,253,467,848.41840,114,310.11,022,893,825.95
一年内到期的非流动负债300,355,532.62616,427.04239,376.24235,673.16
其他流动负债257,111.58333,157.46285,067.49339,159.91
流动负债平衡项目0000
流动负债合计2,581,451,033.212,217,966,680.61,900,495,860.292,096,254,085.23
非流动负债:
长期借款-300,000,000300,000,000300,000,000
租赁负债9,148,258.089,056,271.199,710,647.489,607,219.09
递延收益51,178,488.652,539,781.1751,750,008.953,060,236.63
递延所得税负债42,822,788.1533,761,447.6630,072,673.1622,257,803.44
非流动负债平衡项目0000
非流动负债合计103,149,534.83395,357,500.02391,533,329.54384,925,259.16
负债平衡项目0000
负债合计2,684,600,568.042,613,324,180.622,292,029,189.832,481,179,344.39
所有者权益(或股东权益):
实收资本(或股本)1,828,780,9261,824,366,7261,824,366,7261,824,366,726
资本公积1,485,602,043.171,429,833,873.351,424,972,791.231,420,111,709.11
减:库存股48,070,638---
盈余公积806,811,676.78738,081,985.83738,081,985.83738,081,985.83
未分配利润7,286,306,719.476,940,838,909.736,400,205,342.546,772,539,059.33
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计11,359,430,727.4210,933,121,494.9110,387,626,845.610,755,099,480.27
少数股东权益2,061,751,999.731,985,033,517.151,813,150,705.241,845,050,320.88
股东权益平衡项目0000
股东权益合计13,421,182,727.1512,918,155,012.0612,200,777,550.8412,600,149,801.15
负债和股东权益合计16,105,783,295.1915,531,479,192.6814,492,806,740.6715,081,329,145.54
公告日期2024-03-302023-10-302023-08-242023-04-22
审计意见(境内)标准无保留意见
TOP↑